| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.600 | 559 | 1.618 | 3.538 | 977 | 1.142 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.600 | 559 | 34.529 | 3.675 | 1.230 | 1.142 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.809 | 213 | 4.285 | 3.547 | 1.159 | 2.192 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 791 | 346 | 30.244 | 127 | 72 | -1.050 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 683 | 329 | 29.174 | 17 | 35 | -1.085 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Miazanoaptea S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 34.214 | 33.865 | 720 | 588 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.412 | 4.836 | 37.175 | 2.269 | 2.285 | 58 | 57 | 57 | 57 | 56 |
| Inventories | 4.044 | 4.191 | 3.602 | 2.098 | 2.278 | 58 | 57 | 57 | 57 | 56 |
| Receivables | 0 | 0 | 32.911 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 368 | 644 | 662 | 171 | 8 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | 35.227 | 35.197 | 34.658 | 808 | 810 | -324 | -317 | -318 | -317 | -315 |
| Social Capital | 562 | 557 | 547 | 537 | 527 | 517 | 505 | 507 | 505 | 503 |
| Debts | 3.399 | 3.503 | 3.236 | 2.049 | 1.475 | 382 | 374 | 375 | 374 | 372 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1629 - 1629" | |||||||||
| CAEN Financial Year |
1629
|
|||||||||
Comments - Miazanoaptea S.r.l.